Abbott Laboratories
ABT
NYSE
Last Updated: 6/9/2023 8:03:16 PM
High
Low
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.Abbott Laboratories Company Details
CEO: Mr. Robert B. Ford
Country: US
Industry: Medical Devices
Website: https://www.abbott.com
Exchange: New York Stock Exchange
IPO\Launch Date: 1937-03-01
Abbott Laboratories Company Executive Details
Mr. Hubert L. Allen
Executive Vice President, Gen. Counsel & Sec.
Ms. Andrea F. Wainer
Executive Vice President of Rapid & Molecular Diagnostics
Ms. Melissa Brotz
Vice President of Public Affairs & Corporation Marketing
Mr. Robert E. Funck Jr.
Executive Vice President of Fin. & Chief Financial Officer
Mr. Scott Michael Leinenweber
Vice President of Investor Relations, Licensing & Acquisitions
Abbott Laboratories Latest News
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Published on: 2023-06-07 10:33:12
Impact on Symbol / Company: ABT
View News
2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip
Abbott Labs and Johnson & Johnson have raised their payouts for 51 and 60 consecutive years, respectively. Both companies have solid businesses and a proven ability to be successful in the tricky healthcare industry.
Published on: 2023-06-04 10:15:00
Impact on Symbol / Company: ABT
View News
Abbott accuses one of its former scientists of trade-secrets theft in US court
Healthcare company Abbott Laboratories on Tuesday sued one of its former scientists, accusing him in U.S. court of "secretly downloading" sensitive corporate files containing competitive information about nutrition products.
Published on: 2023-05-31 11:51:15
Impact on Symbol / Company: ABT
View News
Abbott (ABT) Reports Upbeat Cardiomems Sensor Study Result
Abbott's (ABT) MONITOR-HF is the third randomized, controlled trial that will provide significant health benefits to indicated heart failure patients.
Published on: 2023-05-30 10:40:06
Impact on Symbol / Company: ABT
View News
Buy Alert: 3 Undervalued High-Yield Gems For Your Retirement
This article discusses three high-yielding stocks for retirees and income-oriented investors: ONEOK, AbbVie, and Realty Income. ONEOK is a cyclical income play with a 6.5% yield, AbbVie offers a high-quality healthcare yield of 4.2%, and Realty Income provides steady and reliable dividend growth with a 5.2% yield.
Published on: 2023-05-26 09:00:00
Impact on Symbol / Company: ABT
View News
How Dexcom and Abbott are moving beyond diabetes with blood sugar monitoring
CNBC spoke with both Abbott and Dexcom about the technology inside continuous glucose monitors and how they see the technology expanding.
Published on: 2023-05-26 08:00:01
Impact on Symbol / Company: ABT
View News
Medical technology is a good space for cover in recession times, says Mizuho's Anthony Petrone
Anthony Petrone, senior medical devices analyst at Mizuho, joins 'The Exchange' to discuss medical technology gaining share, the bull case for Medtronic, and how medication advancements could impact the medtech sector.
Published on: 2023-05-24 14:52:26
Impact on Symbol / Company: ABT
View News
Abbott (ABT) Unveils Late-Breaking Data on Leadless Pacemaker
Abbott (ABT) study analyzes primary safety and efficacy endpoints in the first 300 people enrolled across 55 centers in the United States, Canada and Europe.
Published on: 2023-05-24 13:13:19
Impact on Symbol / Company: ABT
View News
FTC Investigates Abbott For Alleged Collusion in Federal Baby Formula Contract Bids
Abbott, the nation's largest maker of infant formula, is being investigated by the Federal Trade Commission for potentially anti-competitive federal nutrition program bids.
Published on: 2023-05-24 12:40:49
Impact on Symbol / Company: ABT
View News
10 A-Rated Dividend Aristocrats For The Ultimate High-Yield SWAN Portfolio
The debt ceiling crisis is coming down to the wire. We're possibly already out of time to prevent default and just don't know it. UBS estimates a short default could create a 20% bear market and a one-month default could lead to a 44% crash.
Published on: 2023-05-24 07:20:00
Impact on Symbol / Company: ABT
View News
Abbott, other formula makers face FTC investigation for collusion - WSJ
The U.S. Federal Trade Commission is investigating whether baby-formula makers colluded on bids for attractive state contracts, the Wall Street Journal reported on Wednesday.
Published on: 2023-05-24 00:33:11
Impact on Symbol / Company: ABT
View News
Abbott Laboratories: A Mixed, Yet Expensive Bag
Abbott Laboratories is suffering from a reversal of pandemic trends and its own issues around pediatric nutrition. This creates a tough setup for 2023, as valuations remain demanding.
Published on: 2023-05-22 18:04:04
Impact on Symbol / Company: ABT
View News
Grow your Money
We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures
Services we Offer
We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others
Live Market Data
We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you